CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 8-K Event Shareholder vote results
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 10,000 shares at $8.87 ($88,700)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $8.01 ($24,030)
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
Page 12 of 31 · 616 filings